Atb Cap Markets Cuts Earnings Estimates for Aurora Cannabis

Aurora Cannabis Inc. (TSE:ACB) – Equities researchers at Atb Cap Markets lowered their Q3 2025 earnings estimates for shares of Aurora Cannabis in a report issued on Monday, December 16th. Atb Cap Markets analyst F. Gomes now forecasts that the company will earn ($0.18) per share for the quarter, down from their prior forecast of ($0.13). The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.22) per share. Atb Cap Markets also issued estimates for Aurora Cannabis’ Q4 2025 earnings at ($0.14) EPS, FY2025 earnings at ($0.14) EPS, FY2026 earnings at ($0.23) EPS, FY2027 earnings at ($0.02) EPS and FY2029 earnings at $0.56 EPS.

A number of other equities analysts also recently commented on ACB. ATB Capital lowered their price objective on Aurora Cannabis from C$11.00 to C$8.50 in a research report on Tuesday. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, Aurora Cannabis has a consensus rating of “Moderate Buy” and a consensus price target of C$5.85.

Aurora Cannabis Stock Down 0.5 %

TSE:ACB traded down C$0.03 during midday trading on Thursday, reaching C$6.08. The company had a trading volume of 50,481 shares, compared to its average volume of 987,536. Aurora Cannabis has a 12-month low of C$3.84 and a 12-month high of C$12.85. The firm has a market capitalization of C$332.33 million, a price-to-earnings ratio of -9.65 and a beta of 2.71. The company has a current ratio of 3.76, a quick ratio of 2.48 and a debt-to-equity ratio of 16.95. The stock’s fifty day simple moving average is C$6.89 and its 200-day simple moving average is C$7.56.

Insider Activity at Aurora Cannabis

In related news, Senior Officer Andre Jerome sold 7,712 shares of the firm’s stock in a transaction that occurred on Monday, September 23rd. The stock was sold at an average price of C$7.70, for a total transaction of C$59,382.40.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products.